These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11756198)

  • 1. Liposomal amphotericin B (AmBisome) compared with amphotericin B +/- FMLP induces significantly less in vitro neutrophil aggregation with granulocyte-colony-stimulating factor/dexamethasone-mobilized allogeneic donor neutrophils.
    Sulis ML; Van de Ven C; Henderson T; Anderson L; Cairo MS
    Blood; 2002 Jan; 99(1):384-6. PubMed ID: 11756198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone.
    Dale DC; Liles WC; Llewellyn C; Rodger E; Price TH
    Transfusion; 1998 Aug; 38(8):713-21. PubMed ID: 9709778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study.
    Dignani MC; Anaissie EJ; Hester JP; O'Brien S; Vartivarian SE; Rex JH; Kantarjian H; Jendiroba DB; Lichtiger B; Andersson BS; Freireich EJ
    Leukemia; 1997 Oct; 11(10):1621-30. PubMed ID: 9324280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers.
    Liles WC; Huang JE; Llewellyn C; SenGupta D; Price TH; Dale DC
    Transfusion; 1997 Feb; 37(2):182-7. PubMed ID: 9051093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients.
    Böhme A; Hoelzer D
    Mycoses; 1996; 39(11-12):419-26. PubMed ID: 9144997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collection.
    Heuft HG; Goudeva L; Pulver N; Grigull L; Schwella N; Blasczyk R
    Transfusion; 2005 Apr; 45(4):604-12. PubMed ID: 15819683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation.
    Adkins DR; Goodnough LT; Shenoy S; Brown R; Moellering J; Khoury H; Vij R; DiPersio J
    Blood; 2000 Jun; 95(11):3605-12. PubMed ID: 10828051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony stimulating factor potentiates human polymorphonuclear leukocyte aggregation responses to formyl-methionyl-leucyl-phenylalanine.
    Conti P; Reale M; Barbacane RC; Panara MR; Bongrazio M; Fiore S; Mier JW; Dempsey RA
    Immunol Lett; 1992 Mar; 32(1):71-9. PubMed ID: 1323527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collection of two consecutive neutrophil concentrates for transfusion from donors mobilized with glycosylated granulocyte-CSF plus dexamethasone.
    Heuft HG; Goudeva L; Schwella N; Blasczyk R
    Transfusion; 2004 May; 44(5):750-7. PubMed ID: 15104658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors.
    Heuft HG; Goudeva L; Blasczyk R
    Ann Hematol; 2004 May; 83(5):279-85. PubMed ID: 15060747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte transfusion: stimulation of low dose granulocyte colony-stimulating factor in donors for leukapheresis.
    Nomura A; Ohga S; Matsuzaki A; Kai T; Inaba S; Suda M; Ueda K
    Acta Paediatr Jpn; 1996 Aug; 38(4):317-21. PubMed ID: 8840537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity.
    Sullivan GW; Carper HT; Mandell GL
    Blood; 1993 Apr; 81(7):1863-70. PubMed ID: 7681704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children.
    Tollemar J; Klingspor L; Ringdén O
    Clin Microbiol Infect; 2001; 7 Suppl 2():68-79. PubMed ID: 11525221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts.
    Adkins D; Spitzer G; Johnston M; Velasquez W; Dunphy F; Petruska P
    Transfusion; 1997 Jul; 37(7):737-48. PubMed ID: 9225939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant human granulocyte colony-stimulating factor on human neutrophil adherence in vitro.
    Okada Y; Kawagishi M; Kusaka M
    Experientia; 1990 Oct; 46(10):1050-3. PubMed ID: 1699783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases.
    Dornbusch HJ; Urban CE; Pinter H; Ginter G; Fotter R; Becker H; Miorini T; Berghold C
    Pediatr Hematol Oncol; 1995; 12(6):577-86. PubMed ID: 8589003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.
    Walsh TJ; Yeldandi V; McEvoy M; Gonzalez C; Chanock S; Freifeld A; Seibel NI; Whitcomb PO; Jarosinski P; Boswell G; Bekersky I; Alak A; Buell D; Barret J; Wilson W
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2391-8. PubMed ID: 9736569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotaxis and phagocytosis of the neutrophils mobilized by granulocyte colony-stimulating factor in healthy donors for granulocyte transfusions.
    Katoh M; Takada M; Nakatani N; Cho C; Umeda M
    Am J Hematol; 1995 May; 49(1):96-7. PubMed ID: 7537941
    [No Abstract]   [Full Text] [Related]  

  • 19. Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte-colony-stimulating factor.
    Hubel K; Rodger E; Gaviria JM; Price TH; Dale DC; Liles WC
    Transfusion; 2005 Dec; 45(12):1876-89. PubMed ID: 16371040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
    N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.